Huang, Zhuoshan Shui, Xing Ling, Yesheng Zhou, Linli Shi, Wenqi Luo, Yanting Li, Suhua Zhu, Jieming Yu, Shujie Liu, Jinlai
...
Published in
Clinical cardiology
Recent studies and guidelines have indicated that lipoprotein(a) [Lp(a)]was an independent risk factor of arteriosclerotic cardiovascular disease (ASCVD). This study aimed to determine the relationship between serum Lp(a) levels and the risk of periprocedural myocardial injury following percutaneous coronary intervention (PCI) in coronary heartdise...
Blomström-Lundqvist, Carina Marrouche, Nassir Connolly, Stuart Corp Dit Genti, Valérie Wieloch, Mattias Koren, Andrew Hohnloser, Stefan H
Published in
Clinical cardiology
Atrial fibrillation/atrial flutter (AF/AFL) burden increases with increasing duration of AF/AFL history. Outcomes with dronedarone may also be impacted by duration of AF/AFL history. In this post hoc analysis of ATHENA, efficacy and safety of dronedarone vs placebo were assessed in groups categorized by time from first known AF/AFL episode to rando...
Zhang, Dengshen Mao, Xin Liu, Daxing Zhang, Jian Luo, Gang Luo, Liangliang
Published in
Clinical cardiology
Transcatheter aortic valve replacement (TAVR) is regarded as the most superior alternative treatment approach for patients with aortic stenosis (AS) who are associated with high surgical risk, whereas the effectiveness of TAVR vs surgical aortic valve replacement (SAVR) in low to intermediate surgical risk patients remained inconclusive. This study...
Chen, Chao-Feng Wu, Jing Jin, Chao-Lun Liu, Mei-Jun Xu, Yi-Zhou
Published in
Clinical cardiology
High power shorter duration (HPSD) ablation seen to increase efficacy and safety treating of atrial fibrillation (AF); however, comparative data between HPSD and low power longer duration (LPLD) ablation are limited. We thought that HPSD might bring more clinical benefits. The aim of this meta-analysis was to evaluate the clinical benefits of HPSD ...
Willy, Kevin Frommeyer, Gerrit Dechering, Dirk G Wasmer, Kristina Höwel, Dennis Welle, Sarah S Bögeholz, Nils Ellermann, Christian Wolfes, Julian Rath, Benjamin
...
Published in
Clinical cardiology
Ablation emerged as first line therapy in the treatment of various arrhythmias. Nevertheless, in older patients (pts), decision is often made pro drug treatment as more complications and less benefit are suspected. We hypothesized that different kind of ablations can be performed safely regardless of the pts age. We enrolled all pts aged >80 years ...
Muk, Balázs Vámos, Máté Bógyi, Péter Szabó, Barna Dékány, Miklós Vágány, Dénes Majoros, Zsuzsanna Borsányi, Tünde Duray, Gábor Zoltán Kiss, Róbert Gábor
...
Published in
Clinical cardiology
Recently published studies suggested that digoxin may increase mortality in heart failure with reduced ejection fraction (HFrEF). However, in the vast majority of former trials serum digoxin concentration (SDC) was not measured and therapy was not SDC-guided. To assess the impact of SDC-guided digoxin therapy on mortality in HFrEF patients. Data of...
Khalid, Nauman Ahmad, Sarah Aftab Butt, Nausharwan Kayani, Waleed Tallat
Published in
Clinical cardiology
Kornej, Jelena Henger, Sylvia Seewöster, Timm Teren, Andrej Burkhardt, Ralph Thiele, Holger Thiery, Joachim Scholz, Markus
Published in
Clinical cardiology
Coronary artery disease (CAD) is a significant risk factor for atrial fibrillation (AF). Experimental studies demonstrated that atrial ischemia induced by right coronary artery (RCA) stenosis promote AF triggers and development of electro-anatomical substrate for AF. To analyze the association between AF prevalence and coronary arteries status in t...
Camm, A John Amarenco, Pierre Haas, Sylvia Bach, Miriam Kirchhof, Paulus Kuhls, Silvia Lambelet, Marc Turpie, Alexander G G
Published in
Clinical cardiology
The XANTUS study (NCT01606995) demonstrated low rates of stroke and major bleeding in patients with atrial fibrillation (AF) receiving rivaroxaban in clinical practice for the prevention of thromboembolic events (N = 6784). Because previous real-world studies have not reported gender-dependent responses to rivaroxaban treatment, this sub-analysis o...
Nedios, Sotirios Löbe, Susanne Knopp, Helge Seewöster, Timm Heijman, Jordi Crijns, Harry J G M Arya, Arash Bollmann, Andreas Hindricks, Gerhard Dinov, Borislav
...
Published in
Clinical cardiology
Identifying patients with advanced left atrial (LA) remodeling before catheter ablation (CA) of atrial fibrillation (AF) is crucial. This study aimed to identify echocardiographic parameters associated with changes in anatomy and conduction properties of the left atrium (LA). We examined 75 AF patients prior to CA and measured the intervals from th...
